Diagnostic efficacy of endobronchial ultrasound-guided transbronchoscopic lung biopsy for identifying tuberculous nodules.
Diagnostic efficacy
Endobronchial ultrasound-guided transbronchoscopic lung biopsy
Next-generation sequencing technology
Pulmonary tuberculosis
Xpert MTB/RIF
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
26 Aug 2024
26 Aug 2024
Historique:
received:
01
02
2024
accepted:
19
08
2024
medline:
27
8
2024
pubmed:
27
8
2024
entrez:
26
8
2024
Statut:
epublish
Résumé
Microbiological diagnosis of pulmonary tuberculosis (PTB) is hampered by a low pathogen burden, low compliance and unreliable sputum sampling. Although endobronchial ultrasound-guided transbronchoscopic lung biopsy (EBUS-TBLB) has been found to be useful for the assessment of intrapulmonary nodules in adults, few data are available for the clinical diagnosis of pulmonary tuberculosis. Here, we evaluated EBUS-TBLB as a diagnostic procedure in adult patients with radiologically suspected intrapulmonary tuberculous nodules. This was a retrospective analysis of patients admitted with pulmonary nodules between January 2022 and January 2023 at Hangzhou Red Cross Hospital. All patients underwent EBUS-TBLB, and lung biopsy samples were obtained during hospitalization. All samples were tested for Mycobacterium tuberculosis using acid‒fast smears, Bactec MGIT 960, Xpert MTB/RIF, next-generation sequencing (NGS), and DNA (TB‒DNA) and RNA (TB‒RNA). The concordance between different diagnostic methods and clinical diagnosis was analysed via kappa concordance analysis. The diagnostic efficacy of different diagnostic methods for PTB was analysed via ROC curve. A total of 107 patients were included in this study. Among them, 86 patients were diagnosed by EBUS-TBLB, and the overall diagnostic rate was 80.37%. In addition, 102 enrolled patients had benign lesions, and only 5 were diagnosed with lung tumours. Univariate analysis revealed that the diagnostic rate of EBUS-TBLB in pulmonary nodules was related to the location of the probe. The consistency analysis and ROC curve analysis revealed that NGS had the highest concordance with the clinical diagnosis results (agreement = 78.50%, κ = 0.558) and had the highest diagnostic efficacy for PTB (AUC = 0.778). In addition, Xpert MTB/RIF + NGS had the highest concordance with the clinical diagnosis results (agreement = 84.11%, κ = 0.667) and had the highest efficacy in the diagnosis of PTB (AUC = 0.826). EBUS-TBLB is a sensitive and safe method for the diagnosis of pathological pulmonary nodules. Xpert MTB/RIF combined with NGS had the highest diagnostic efficacy and can be used in the initial diagnosis of PTB.
Sections du résumé
BACKGROUND
BACKGROUND
Microbiological diagnosis of pulmonary tuberculosis (PTB) is hampered by a low pathogen burden, low compliance and unreliable sputum sampling. Although endobronchial ultrasound-guided transbronchoscopic lung biopsy (EBUS-TBLB) has been found to be useful for the assessment of intrapulmonary nodules in adults, few data are available for the clinical diagnosis of pulmonary tuberculosis. Here, we evaluated EBUS-TBLB as a diagnostic procedure in adult patients with radiologically suspected intrapulmonary tuberculous nodules.
METHODS
METHODS
This was a retrospective analysis of patients admitted with pulmonary nodules between January 2022 and January 2023 at Hangzhou Red Cross Hospital. All patients underwent EBUS-TBLB, and lung biopsy samples were obtained during hospitalization. All samples were tested for Mycobacterium tuberculosis using acid‒fast smears, Bactec MGIT 960, Xpert MTB/RIF, next-generation sequencing (NGS), and DNA (TB‒DNA) and RNA (TB‒RNA). The concordance between different diagnostic methods and clinical diagnosis was analysed via kappa concordance analysis. The diagnostic efficacy of different diagnostic methods for PTB was analysed via ROC curve.
RESULTS
RESULTS
A total of 107 patients were included in this study. Among them, 86 patients were diagnosed by EBUS-TBLB, and the overall diagnostic rate was 80.37%. In addition, 102 enrolled patients had benign lesions, and only 5 were diagnosed with lung tumours. Univariate analysis revealed that the diagnostic rate of EBUS-TBLB in pulmonary nodules was related to the location of the probe. The consistency analysis and ROC curve analysis revealed that NGS had the highest concordance with the clinical diagnosis results (agreement = 78.50%, κ = 0.558) and had the highest diagnostic efficacy for PTB (AUC = 0.778). In addition, Xpert MTB/RIF + NGS had the highest concordance with the clinical diagnosis results (agreement = 84.11%, κ = 0.667) and had the highest efficacy in the diagnosis of PTB (AUC = 0.826).
CONCLUSION
CONCLUSIONS
EBUS-TBLB is a sensitive and safe method for the diagnosis of pathological pulmonary nodules. Xpert MTB/RIF combined with NGS had the highest diagnostic efficacy and can be used in the initial diagnosis of PTB.
Identifiants
pubmed: 39187759
doi: 10.1186/s12879-024-09761-8
pii: 10.1186/s12879-024-09761-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
861Informations de copyright
© 2024. The Author(s).
Références
Jia Z, Cheng S, Ma Y, Zhang T, Bai L, Xu W, et al. Tuberculosis burden in China: a high prevalence of pulmonary tuberculosis in household contacts with and without symptoms. BMC Infect Dis. 2014;14:64. https://doi.org/10.1186/1471-2334-14-64 .
doi: 10.1186/1471-2334-14-64
pubmed: 24502559
pmcid: 3918223
Sossen B, Richards AS, Heinsohn T, Frascella B, Balzarini F, Oradini-Alacreu A, et al. The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysis. Lancet Respiratory Med. 2023;11(4):367–79. https://doi.org/10.1016/s2213-2600(23)00097-8 .
doi: 10.1016/s2213-2600(23)00097-8
Margarit A, Simó S, Rozas L, Deyà-Martínez À, Barrabeig I, Gené A, et al. Adolescent tuberculosis; a challenge and opportunity to prevent community transmission. Pediatr (Barc). 2017;86(3):110–4. https://doi.org/10.1016/j.anpedi.2016.03.009 .
doi: 10.1016/j.anpedi.2016.03.009
Teo AKJ, Singh SR, Prem K, Hsu LY, Yi S. Delayed diagnosis and treatment of pulmonary tuberculosis in high-burden countries: a systematic review protocol. BMJ open. 2019;9(7):e029807. https://doi.org/10.1136/bmjopen-2019-029807 .
doi: 10.1136/bmjopen-2019-029807
pubmed: 31289094
pmcid: 6629411
Mustafa H, Shah NN, Shahnawaz M, Yousuf M. Role of Gene Xpert in smear negative pulmonary tuberculosis. Indian J Tuberc. 2022;69(4):552–7. https://doi.org/10.1016/j.ijtb.2021.08.035 .
doi: 10.1016/j.ijtb.2021.08.035
pubmed: 36460388
Chen X, Zhao J, Chen L, Chen Y, Liu J. Pulmonary Talaromyces marneffei misdiagnosed as smear-negative pulmonary tuberculosis. Clin Respir J. 2023;17(8):816–8. https://doi.org/10.1111/crj.13661 .
doi: 10.1111/crj.13661
pubmed: 37408501
pmcid: 10435955
Feng JY, Lin CJ, Wang JY, Chien ST, Lin CB, Huang WC, et al. Nucleic acid amplification tests reduce delayed diagnosis and misdiagnosis of pulmonary tuberculosis. Sci Rep. 2022;12(1):12064. https://doi.org/10.1038/s41598-022-16319-8 .
doi: 10.1038/s41598-022-16319-8
pubmed: 35835940
pmcid: 9283405
Pourabdollah M, Shamaei M, Karimi S, Karimi M, Kiani A, Jabbari HR. Transbronchial lung biopsy: the pathologist’s point of view. Clin Respir J. 2016;10(2):211–6. https://doi.org/10.1111/crj.12207 .
doi: 10.1111/crj.12207
pubmed: 25185518
Zou X, Zhu Y, Hu Q, Qi Q, Hua H, Fei F, et al. Diagnostic value of ultrasound-guided transbronchial lung biopsy in peripheral tuberculous pulmonary lesions. Diagn Cytopathol. 2022;50(12):572–8. https://doi.org/10.1002/dc.25041 .
doi: 10.1002/dc.25041
pubmed: 36317761
Lin CK, Fan HJ, Yu KL, Chang LY, Wen YF, Keng LT, et al. Effectiveness of Endobronchial Ultrasound-guided Transbronchial Biopsy Combined with tissue culture for the diagnosis of Sputum Smear-negative pulmonary tuberculosis. Front Microbiol. 2022;13:847479. https://doi.org/10.3389/fmicb.2022.847479 .
doi: 10.3389/fmicb.2022.847479
pubmed: 35547142
pmcid: 9081838
Lim V, Chin RYZ, Kee A, Ng J, See KC. Diagnostic yield and safety of CP-EBUS-TBNA and RP-EBUS-TBLB under moderate sedation: a single-center retrospective audit. Diagnostics (Basel Switzerland). 2022;12(11). https://doi.org/10.3390/diagnostics12112576 .
Hong KS, Lee KH, Chung JH, Shin KC, Jin HJ, Jang JG, et al. Utility of Radial Probe Endobronchial Ultrasound guided Transbronchial Lung Biopsy in Bronchus sign negative Peripheral Pulmonary lesions. J Korean Med Sci. 2021;36(24):e176. https://doi.org/10.3346/jkms.2021.36.e176 .
doi: 10.3346/jkms.2021.36.e176
pubmed: 34155838
pmcid: 8216993
Acharya B, Acharya A, Gautam S, Ghimire SP, Mishra G, Parajuli N, et al. Advances in diagnosis of tuberculosis: an update into molecular diagnosis of Mycobacterium tuberculosis. Mol Biol Rep. 2020;47(5):4065–75. https://doi.org/10.1007/s11033-020-05413-7 .
doi: 10.1007/s11033-020-05413-7
pubmed: 32248381
Migliori GB, Caminero Luna J, Kurhasani X, van den Boom M, Visca D, D’Ambrosio L, et al. History of prevention, diagnosis, treatment and rehabilitation of pulmonary sequelae of tuberculosis. Presse Med. 2022;51(3):104112. https://doi.org/10.1016/j.lpm.2022.104112 .
doi: 10.1016/j.lpm.2022.104112
pubmed: 35124102
Kong L, Xie B, Liu Q, Hua L, Bhusal A, Bao C, et al. Application of acid-fast staining combined with GeneXpert MTB/RIF in the diagnosis of non-tuberculous mycobacteria pulmonary disease. Int J Infect Diseases: IJID: Official Publication Int Soc Infect Dis. 2021;104:711–7. https://doi.org/10.1016/j.ijid.2020.12.091 .
doi: 10.1016/j.ijid.2020.12.091
Bhirud P, Joshi A, Hirani N, Chowdhary A. Rapid laboratory diagnosis of pulmonary tuberculosis. Int J Mycobacteriology. 2017;6(3):296–301. https://doi.org/10.4103/ijmy.ijmy_61_17 .
doi: 10.4103/ijmy.ijmy_61_17
Sivaramakrishnan G, Subramanyam B, Kumar MP, Golla R, Tripathy SP, Mondal R. Validation of bedaquiline drug-susceptibility testing by BACTEC MGIT 960 system for Mycobacterium tuberculosis. Int J Mycobacteriology. 2019;8(4):329–32. https://doi.org/10.4103/ijmy.ijmy_151_19 .
doi: 10.4103/ijmy.ijmy_151_19
Govindan SA, Yadav R, Vaidya PC, Sethi S, Mehra N, Das RR, et al. Comparison of performances of loop-mediated isothermal amplification, XPERT MTB/RIF and BACTEC MGIT in the diagnosis of childhood tuberculosis. J Paediatr Child Health. 2021;57(6):847–53. https://doi.org/10.1111/jpc.15334 .
doi: 10.1111/jpc.15334
Zou X, Zhu Y, Qin Y, Fei F, Chen Y, Wang P, et al. Value analysis of next-generation sequencing combined with Xpert in early precise diagnosis of pulmonary tuberculosis. Diagn Microbiol Infect Dis. 2023;107(1):115921. https://doi.org/10.1016/j.diagmicrobio.2023.115921 .
doi: 10.1016/j.diagmicrobio.2023.115921
pubmed: 37478548
Galamay LC, Chee CBE, Khin Mar KW, Lau BQ, Wang YT. Smear-positive pulmonary tuberculosis patients with previously abnormal chest radiographs: missed opportunities for early diagnosis. Singap Med J. 2021;62(6):296–9. https://doi.org/10.11622/smedj.2020027 .
doi: 10.11622/smedj.2020027
Afsar I, Gunes M, Er H, Gamze Sener A. Comparison of culture, microscopic smear and molecular methods in diagnosis of tuberculosis. Rev Esp Quimioter. 2018;31(5):435–8.
pubmed: 30229645
pmcid: 6194869
Cardona PJ. Pathogenesis of tuberculosis and other mycobacteriosis. Enfermedades infecciosas y microbiologia clinica. (English ed). 2018;36(1):38–46. https://doi.org/10.1016/j.eimc.2017.10.015 .
doi: 10.1016/j.eimc.2017.10.015
Bouzeyen R, Javid B. Therapeutic vaccines for tuberculosis: an overview. Front Immunol. 2022;13:878471. https://doi.org/10.3389/fimmu.2022.878471 .
doi: 10.3389/fimmu.2022.878471
pubmed: 35812462
pmcid: 9263712
Liebenberg D, Gordhan BG, Kana BD. Drug resistant tuberculosis: implications for transmission, diagnosis, and disease management. Front Cell Infect Microbiol. 2022;12:943545. https://doi.org/10.3389/fcimb.2022.943545 .
doi: 10.3389/fcimb.2022.943545
pubmed: 36211964
pmcid: 9538507
Yan L, Xiao H, Zhang Q. Systematic review: Comparison of Xpert MTB/RIF, LAMP and SAT methods for the diagnosis of pulmonary tuberculosis. Tuberc (Edinb Scotl). 2016;96:75–86. https://doi.org/10.1016/j.tube.2015.11.005 .
doi: 10.1016/j.tube.2015.11.005
Huang CT, Tsai YJ, Ho CC, Yu CJ. Atypical cells in pathology of endobronchial ultrasound-guided transbronchial biopsy of peripheral pulmonary lesions: incidence and clinical significance. Surg Endosc. 2019;33(6):1783–8. https://doi.org/10.1007/s00464-018-6452-1 .
doi: 10.1007/s00464-018-6452-1
pubmed: 30203208
Zhan P, Zhu QQ, Miu YY, Liu YF, Wang XX, Zhou ZJ, et al. Comparison between endobronchial ultrasound-guided transbronchial biopsy and CT-guided transthoracic lung biopsy for the diagnosis of peripheral lung cancer: a systematic review and meta-analysis. Translational lung cancer Res. 2017;6(1):23–34. https://doi.org/10.21037/tlcr.2017.01.01 .
doi: 10.21037/tlcr.2017.01.01
Lee J, Kim C, Seol HY, Chung HS, Mok J, Lee G, et al. Safety and Diagnostic Yield of Radial Probe Endobronchial Ultrasound-guided biopsy for peripheral lung lesions in patients with idiopathic pulmonary fibrosis: a Multicenter cross-sectional study. Respiration. 2022;101(4):401–7. https://doi.org/10.1159/000520034 .
doi: 10.1159/000520034
pubmed: 34802001
Xia Y, Li Q, Zhong C, Wang K, Li S. Inheritance and innovation of the diagnosis of peripheral pulmonary lesions. Ther Adv Chronic Dis. 2023;14:20406223221146723. https://doi.org/10.1177/20406223221146723 .
doi: 10.1177/20406223221146723
pubmed: 36743297
pmcid: 9896091
Herth FJ, Ernst A, Becker HD. Endobronchial ultrasound-guided transbronchial lung biopsy in solitary pulmonary nodules and peripheral lesions. Eur Respir J. 2002;20(4):972–4. https://doi.org/10.1183/09031936.02.00032001 .
doi: 10.1183/09031936.02.00032001
pubmed: 12412691
Zaric B, Stojsic V, Sarcev T, Stojanovic G, Carapic V, Perin B, et al. Advanced bronchoscopic techniques in diagnosis and staging of lung cancer. J Thorac Dis. 2013;5(Suppl 4):S359–70. https://doi.org/10.3978/j.issn.2072-1439.2013.05.15 .
doi: 10.3978/j.issn.2072-1439.2013.05.15
pubmed: 24102008
pmcid: 3791497
Tay JH, Irving L, Antippa P, Steinfort DP. Radial probe endobronchial ultrasound: factors influencing visualization yield of peripheral pulmonary lesions. Respirology. 2013;18(1):185–90. https://doi.org/10.1111/j.1440-1843.2012.02276.x .
doi: 10.1111/j.1440-1843.2012.02276.x
pubmed: 23035636
Organization WH, WHO Guidelines Approved by the Guidelines Review Committee. Automated real-time nucleic acid amplification technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children. Policy Update. Geneva; 2013.
Rachow A, Zumla A, Heinrich N, Rojas-Ponce G, Mtafya B, Reither K, et al. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay–a clinical validation study. PLoS ONE. 2011;6(6):e20458. https://doi.org/10.1371/journal.pone.0020458 .
doi: 10.1371/journal.pone.0020458
pubmed: 21738575
pmcid: 3126807
Steingart KR, Henry M, Laal S, Hopewell PC, Ramsay A, Menzies D, et al. Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. Postgrad Med J. 2007;83(985):705–12.
doi: 10.1136/thx.2006.075754
pubmed: 17989270
pmcid: 2734443
Chao Y, Li J, Gong Z, Li C, Ye M, Hong Q, et al. Rapid discrimination between tuberculosis and sarcoidosis using next-generation sequencing. Int J Infect Dis. 2021;108:129–36. https://doi.org/10.1016/j.ijid.2021.05.028 .
doi: 10.1016/j.ijid.2021.05.028
pubmed: 34004327
Liu X, Chen Y, Ouyang H, Liu J, Luo X, Huang Y, et al. Tuberculosis diagnosis by Metagenomic Next-generation sequencing on Bronchoalveolar Lavage Fluid: a cross-sectional analysis. Int J Infect Dis. 2021;104:50–7. https://doi.org/10.1016/j.ijid.2020.12.063 .
doi: 10.1016/j.ijid.2020.12.063
pubmed: 33359946